Immobilizing calcium-dependent affinity ligand onto iron oxide nanoparticles for mild magnetic mAb separationShow others and affiliations
2025 (English)In: Biotechnology Reports, E-ISSN 2215-017X, Vol. 45, article id e00864
Article in journal (Refereed) Published
Abstract [en]
Current downstream processing of monoclonal antibodies (mAbs) is limited in throughput and requires harsh pH conditions for mAb elution from Protein A affinity ligands. The use of an engineered calcium-dependent ligand (ZCa) in magnetic separation applications promises improvements due to mild elution conditions, fast processability, and process integration prospects. In this work, we synthesized and evaluated three magnetic nanoparticle types immobilized with the cysteine-tagged ligand ZCa-cys. Ligand homodimers were physically immobilized onto bare iron oxide nanoparticles (MNP) and MNP coated with tetraethyl orthosilicate (MNP@TEOS). In contrast, ZCa-cys was covalently and more site-directedly immobilized onto MNP coated with (3-glycidyloxypropyl)trimethoxysilane (MNP@GPTMS) via a preferential cysteine-mediated epoxy ring opening reaction. Both coated MNP showed suitable characteristics, with MNP@TEOS@ZCa-cys demonstrating larger immunoglobulin G (IgG) capacity (196 mg g−1) and the GPTMS-coated particles showing faster magnetic attraction and higher IgG recovery (88 %). The particles pave the way for the development of calcium-dependent magnetic separation processes.
Place, publisher, year, edition, pages
Elsevier BV , 2025. Vol. 45, article id e00864
Keywords [en]
Anything but conventional chromatography (abc), Downstream processing, Epoxy, Physical and covalent immobilization, Silica
National Category
Bioprocess Technology
Identifiers
URN: urn:nbn:se:kth:diva-357691DOI: 10.1016/j.btre.2024.e00864Scopus ID: 2-s2.0-85210352120OAI: oai:DiVA.org:kth-357691DiVA, id: diva2:1920798
Note
QC 20241213
2024-12-122024-12-122024-12-13Bibliographically approved